Biomarin Pharmaceutical (NASDAQ:BMRN) has outperformed the market over the past 20 years by 6.85% on an annualized basis producing an average annual return of 15.04%. Currently, Biomarin Pharmaceutical has a market capitalization of $16.45 billion. Buying $1000 In BMRN: If an investor had bought $1000 of BMRN stock 20 years ago, it would be worth $16,523.90 today based on a price of $86.42 for BMRN at the time of writing. Biomarin Pharmaceutical’s Performance Over Last 20 YearsFinally — what’s the point of all this? The key insight to take from this article is to note how much of a difference…